Management of the Hospitalized Patient with Acute Colitis.

Area of Science:

• Gastroenterology
• Internal Medicine
• Coloproctology

Background:

• Acute severe ulcerative colitis (ASUC) affects 20-30% of ulcerative colitis patients.
• ASUC is a rapidly progressive and severe form of colitis.
• Effective management hinges on early recognition and specialized care.

Purpose of the Study:

• To outline the cornerstone of management for acute severe ulcerative colitis.
• To emphasize early interventions and risk mitigation strategies.
• To define criteria for escalating therapy and surgical considerations.

Main Methods:

• Exclusion of infections and other differential diagnoses.
• Initiation of parenteral corticosteroids for inflammation control.
• Early deep vein thrombosis (DVT) prophylaxis.
• Objective assessment for response to steroid therapy within 72 hours.
• Consideration of second-line therapies (infliximab, cyclosporine) for non-responders.
• Surgical colectomy as a salvage option for refractory disease or complications.

Main Results:

• Parenteral corticosteroids are the initial treatment for inflammation.
• DVT prophylaxis is essential due to high thromboembolic risk.
• Early identification of non-responders guides timely escalation to rescue therapies.
• Second-line agents like infliximab and cyclosporine are effective options.
• Colectomy remains a critical salvage procedure for severe or complicated ASUC.

Conclusions:

• Multidisciplinary management, early recognition, and prompt treatment are vital for ASUC.
• Risk stratification and timely therapeutic adjustments improve outcomes.
• Aggressive medical management and surgical intervention are key components of ASUC care.